Health Products

Blood Group Reagent Anti-Lea (Murine Monoclonal)Bioclone

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - Haematology
Product: Blood Group Reagent Anti-Lea (Murine Monoclonal)Bioclone
Issue: Medical devices - Performance
What to do: Contact the manufacturer if you require additional information.
Audience: Healthcare
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberModel or catalogue numberAffected products
LAB167A
LAB169A
LAB168A
LAB170A
715280Blood Group Reagent Anti-Lea (Murine Monoclonal)Bioclone

Issue

During an internal investigation, Ortho identified that the Anti-Lea (Anti-Le1) lot LAB170A was demonstrating weak to no reactivity with Lea positive cells. The results of the investigation demonstrated that lot LAB170A was more than two dilutions lower than the control lot, thereby these lots were failing internal testing. This issue of weak/no reactivity of Anti-Lea (Anti-Le1) antisera may be detectable in both quality control (QC) and patient samples based on weakened strength of reactivity.

Recall start date: June 29, 2022

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime